MC
BMY icon

Mirabaud & Cie’s Bristol-Myers Squibb BMY Stock Holding History

Mirabaud & Cie’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,820
Closed -$269K – 60
2025
Q2 		$269K Hold
5,820
– – 0.09% 57
2025
Q1 		$355K Hold
5,820
– – 0.12% 50
2024
Q4 		$329K Hold
5,820
– – 0.11% 53
2024
Q3 		$301K Hold
5,820
– – 0.09% 53
2024
Q2 		$242K Sell
5,820
-2,800
-32% -$125K 0.08% 57
2024
Q1 		$467K Hold
8,620
– – 0.16% 48
2023
Q4 		$442K Buy
+8,620
New +$452K 0.15% 52

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Mirabaud & Cie's BMY Position: Q3 2025 in Review

Mirabaud & Cie sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 5,820 shares — an estimated $269K sold.

Mirabaud & Cie first reported a position in BMY in Q4 2023 and held it in 7 quarters. The position peaked at $467K in Q1 2024. 2,276 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Mirabaud & Cie reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • Mirabaud & Cie sold 5,820 Bristol-Myers Squibb shares in Q3 2025, an estimated $269K.
  • Mirabaud & Cie first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 7 quarters.
  • Mirabaud & Cie's Bristol-Myers Squibb position peaked at $467K in Q1 2024.
  • 2,276 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Mirabaud & Cie's 13F filing for Q3 2025, filed 16 Oct 2025.